Biotech firms show interest in developing antibiotics

05/17/2011 | Bloomberg

Biotech companies are increasing research into antibiotics, which large drugmakers are less frequently pursuing because of a lack of revenue opportunities, as strains of drug-resistant bacteria begin to emerge. One such company is Optimer Pharmaceuticals, which expects to get FDA approval by the end of the month for Dificid, an antibiotic against stomach infection.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC